Researcher
Armand Van Deun
- Keywords:B230-bacteriology, B680-public-health, B725-diagnostics, B726-clinical-biology
Affiliations
- Mycobacteriology (Research unit)
Member
From31 Dec 1998 → 29 Nov 2018 - Mycobacteriology (Research unit)
Member
From31 Dec 1998 → 16 Apr 2015
Projects
1 - 4 of 4
- Novel High-Dose Tuberculosis Retreatment Regimens: How to overcome resistance without creating more?From1 Oct 2018 → Today
- Significance of initial isoniazid resistance for outcome of standard TB treatment and its detection by line-probe assaysFrom1 Jan 2018 → 31 Dec 2018
- Trend of fluoroquinolone resistance among the MDR in DF BangladeshFrom1 Jan 2017 → 31 Dec 2018
- Validity and feasability of use of a rapid and innovative test for detection of Multi Drug Resistant (MDR) TB cases in Kinshasa, DRCFrom1 Mar 2009 → 6 Jul 2018
Publications
41 - 50 of 142
- Should gatifloxacin be included in the model list of essential medicines?(2018)
Authors: Chen-Yuan Chiang, Arnaud Trebucq, Alberto Piubello, Hans L. Rieder, A Van Deun
- Xpert Ultra can unambiguously identify specific rifampin resistance-conferring mutations(2018)
Authors: Kamela Charmaine Sy Ng, Armand Van Deun, Conor J. Meehan, Gabriela Torrea, Michèle Driesen, Siemon Gabriëls, L Rigouts, Emmanuel André, Bouke de Jong
- Isoniazid resistance levels of Mycobacterium tuberculosis can largely be predicted by high-confidence resistance-conferring mutations(2018)
Authors: Pauline Lempens, Conor J. Meehan, Koen Vandelannoote, K Fissette, P De Rijk, Armand Van Deun, L Rigouts, Bouke de Jong
- Principles for constructing a tuberculosis treatment regimen(2018)
Authors: Armand Van Deun, Tom Decroo, A Piubello, Bouke de Jong, Lutgarde Lynen, H L Rieder
Pages: 239-245 - Twenty years of rifampicin resistance surveillance in Bangladesh: periodic vs. continuous monitoring(2018)
Authors: Armand Van Deun, K.J.M. Aung, M.A. Hossain, M. A. H. Salim, M Gumusboga, Bouke de Jong, Tom Decroo
Pages: 1450-1461 - Exploratory results of intensification of the use of the GeneXpert (R) MTB/RIF as support in the tracking the TB and TB-RR in Kinshasa(2017)
Authors: A. Bele, S. Musala, L. Okenge, J. C. Kasereka, J. F. Baleka, Brian Bakoko, Armand Van Deun, M Kaswa
Pages: 212-212 - How should discordance between molecular and growth-based assays for rifampicin resistance be investigated?(2017)
Authors: S. Hofmann-Thiel, H Hoffmann, D. Hillemann, L Rigouts, Armand Van Deun, Katharina Kranzer
Pages: 721-726 - Shortened multidrug-resistant tuberculosis regimens overcome low-level fluoroquinolone resistance(2017)
Authors: A Van Deun, Chen-Yuan Chiang
- Rationale for high-dose isoniazid in the treatment of multidrug-resistant tuberculosis(2017)
Authors: Hans L. Rieder, A Van Deun
Pages: 123-124 - Shorter regimens for multidrug-resistant tuberculosis should also be applicable in Europe(2017)
Authors: Einar Heldal, A Van Deun, Chen-Yuan Chiang, Hans L. Rieder